La línea de investigación está centrada en el estudio de las bases moleculares de lesión celular a la diabetes y sus condiciones metabólicas asociades tanto en modelos experimentales celulares y animales como en humanos.
MAURICIO PUENTE, DIEGO FGS
dmauricio@santpau.cat
Chico Ballesteros, Ana Isabel FGS
Corcoy Pla, Rosa FGS
Cubero Marcos, Jose Maria FGS
Cuixart Carruesco, Gemma IR
Garcia Patterson, Apolonia Gabriela IR
Genua Trullos, Idoia IR
Gonzalez Blanco, Cintia FGS
Julve Gil, Josep IR
Lopez Argudo, Alicia FGS
Martinez Mores, Santiago IR
Mateu Salat, Manuel IR
Mato Matute, Eugenia CIBERBBN
Mendoza Mathison, Lilian Cristina FGS
Miñambres Donaire, Inka FGS
Perez Perez, Antonio FGS
Pujol Abajo, Montserrat FGS
Rojo Lopez, Marina Idalia IR
Rossell Rusiñol, Joana CIBERDEM
Stantonyonge Sesnic, Nicole FGS
Subias Burrell, Miguel IR
Vlacho Bogdan, CIBERDEM
La línea de investigación está centrada en el estudio de las bases moleculares de lesión celular a la diabetes y sus condiciones metabólicas asociades tanto en modelos experimentales celulares y animales como en humanos.
MAURICIO PUENTE, DIEGO FGS
dmauricio@santpau.cat
Chico Ballesteros, Ana Isabel FGS
Corcoy Pla, Rosa FGS
Cubero Marcos, Jose Maria FGS
Cuixart Carruesco, Gemma IR
Garcia Patterson, Apolonia Gabriela IR
Genua Trullos, Idoia IR
Gonzalez Blanco, Cintia FGS
Julve Gil, Josep IR
Lopez Argudo, Alicia FGS
Martinez Mores, Santiago IR
Mateu Salat, Manuel IR
Mato Matute, Eugenia CIBERBBN
Mendoza Mathison, Lilian Cristina FGS
Miñambres Donaire, Inka FGS
Perez Perez, Antonio FGS
Pujol Abajo, Montserrat FGS
Rojo Lopez, Marina Idalia IR
Rossell Rusiñol, Joana CIBERDEM
Stantonyonge Sesnic, Nicole FGS
Subias Burrell, Miguel IR
Vlacho Bogdan, CIBERDEM
Amor AJ, Castelblanco E, Hernández M, Gimenez M, Granado-Casas M, Blanco J, Soldevila B, Esmatjes E, Conget I, Alonso N, Ortega E, Mauricio D. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles. (2020) CARDIOVASC DIABETOL 19:126. doi: 10.1186/s12933-020-01099-0.
IF: 9,951
Armario P, Brotons C, Elosua R, Alonso de Leciñana M, Castro A, Clarà A, Cortés O, Díaz Rodriguez Á, Herranz M, Justo S, Lahoz C, Pedro-Botet J, Pérez Pérez A, Santamaria R, Tresserras R, Aznar Lain S, Royo-Bordonada MÁ. Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines]. (2020) REV ESP SALUD PUBLICA. 94:e202009102. PMID: 32915170.
IF: 0,756
Ballesteros Pomar MD, Vilarrasa García N, Rubio Herrera MÁ, Barahona MJ, Bueno M, Caixàs A, Calañas Continente A, Ciudin A, Cordido F, de Hollanda A, Diaz MJ, Flores L, García Luna PP, García Pérez-Sevillano F, Goday A, Lecube A, López Gómez JJ, Miñambres I, Morales Gorria MJ, Morinigo R, Nicolau J, Pellitero S, Salvador J, Valdés S, Bretón Lesmes I. The SEEN comprehensive clinical survey of adult obesity: Executive summary. (2020) ENDOCRINOL DIAB NUTR. S2530-0164(20)30162-2. doi: 10.1016/j.endinu.2020.05.003.
IF: 1,417
Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. (2020) ENDOCRINOL DIABETES NUTR. 67:355-356. doi: 10.1016/j.endinu.2020.04.001.
IF: 1,417
Benitez-Amaro A., Revuelta-Lopez E., Bornachea O., Cedo L., Vea A., Herrero L., Roglans N., Soler-Botija C., de Gonzalo-Calvo D., Nasarre L., Camino-Lopez S., Garcia E., Mato E., Blanco-Vaca F., Bayes-Genis A., Sebastian D., Laguna J.C., Serra D., Zorzano A., Escola-Gil J.C., Llorente-Cortes V. (2020) Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity. METABOLISM, 106 (), -.
IF: 8,694
Bermudez-Lopez M., Martinez-Alonso M., Castro-Boque E., Betriu A., Cambray S., Farras C., Barbe F., Pamplona R., Lecube A., Mauricio D., Purroy F., Valdivielso J.M., Fernandez E. (2020) Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study Localización y carga de ateromatosis subclínica en población con un riesgo cardiovascular bajo-moderado: estudio ILERVAS. REV ESP CARDIOL, (), -.
IF: 4,753
Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. (2020) DIABETES 69:2037-2047. doi: 10.2337/dbi20-0017.
IF: 9,461
Castelblanco E, Sanjurjo L, Barranco-Altirriba M, Falguera M, Hernández M, Soldevila B, Sarrias MR, Franch-Nadal J, Arroyo JA, Fernandez-Real JM, Alonso N, Mauricio D. The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus. (2020) J CLIN MED 9:E1700. doi: 10.3390/jcm9061700.
IF: 4,241
Cedo L., Metso J., Santos D., Garcia-Leon A., Plana N., Sabate-Soler S., Rotllan N., Rivas-Urbina A., Mendez-Lara K.A., Tondo M., Girona J., Julve J., Pallares V., Benitez-Amaro A., Llorente-Cortes V., Perez A., Gomez-Coronado D., Ruotsalainen A.-K., Levonen A.-L., Sanchez-Quesada J.L., Masana L., Kovanen P.T., Jauhiainen M., Lee-Rueckert M., Blanco-Vaca F., Escola-Gil J.C. (2020) LDL receptor regulates the reverse transport of macrophage-derived unesterified cholesterol via concerted action of the HDL-LDL Axis: Insight from mouse models. CIRC RES, 127 (6), 778-792.
IF: 17,367
Cheng A., Bailey T.S., Mauricio D., Roussel R. (2020) Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues. DIABETES-METAB RES, 36 (7), -.
IF: 4,876
Chico A, Corcoy R. Intensive Insulin Therapy (= Basal-Bolus). AM J THER. 2020. doi: 10.1097/MJT.0000000000001152. Online ahead of print.
IF: 2,688
Codina M, Corcoy R, Goya MM; en representación del GEDE Consenso del Grupo Español de Diabetes y Embarazo (GEDE). Update of the hyperglycemia Gestational diagnosis during the COVID-19 pandemic. (2020) ENDOCRINOL DIAB NUTR. 67:545-552. doi: 10.1016/j.endinu.2020.05.002.
IF: 1,417
Corcoy R., Mendoza L.C., Simmons D., Desoye G., Adelantado J.M., Chico A., Devlieger R., van Assche A., Galjaard S., Timmerman D., Lapolla A., Dalfra M.G., Bertolotto A., Harreiter J., Wender-Ozegowska E., Zawiejska A., Kautzky-Willer A., Dunne F.P., Damm P., Mathiesen E.R., Jensen D.M., Andersen L.L.T., Tanvig M., Hill D.J., Jelsma J.G., Snoek F.J., Kofeler H., Trotzmuller M., Lips P., van Poppel M.N.M. (2020) The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency. CLIN NUTR, 39 (3), 976-984.
IF: 7,324
De Hollanda A, Lecube A, Rubio MA, Sánchez E, Vilarrasa N, Oliva JG, Fernández-Soto ML, Salas-Salvadó J, Ballesteros-Pomar MD, Ciudin A, Torres F, Vidal C, Morales MJ, Valdés S, Pellitero S, Miñambres I, Masmiquel L, Goday A, Suarez L, Flores L, et al. New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”. (2020) J CLIN MED. 9:1070. doi: 10.3390/jcm9041070.
IF: 4,241
Falguera M., Vilanova M.B., Alcubierre N., Granado-Casas M., Marsal J.R., Miro N., Cebrian C., Mollo A., Franch-Nadal J., Mata-Cases M., Castelblanco E., Mauricio D. (2020) Prevalence of pre-diabetes and undiagnosed diabetes in the Mollerussa prospective observational cohort study in a semi-rural area of Catalonia. BMJ OPEN, 10 (1), -.
IF: 2,692
Freemantle N., Mauricio D., Giaccari A., Bailey T., Roussel R., Franco D., Berthou B., Pilorget V., Westerbacka J., Bosnyak Z., Bonnemaire M., Cali A.M.G., Nguyen-Pascal M.-L., Penfornis A., Perez-Maraver M., Seufert J., Sullivan S.D., Wilding J., Wysham C., Davies M. (2020) Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. CURR MED RES OPIN, 36 (4), 571-581.
IF: 2,580
Freemantle N., Bonadonna R.C., Gourdy P., Mauricio D., Mueller-Wieland D., Bigot G., Ciocca A., Mauquoi C., Rollot M., Bonnemaire M. (2020) Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: Protocol of REALI project. BMJ OPEN, 10 (4), e033659-.
IF: 2,692
Garcia-Patterson A., Ovejero D., Minambres I., Chico A., Gil P.A., Martinez M.-J., Adelantado J.M., de Leiva A., Gich I., Desoye G., de Mouzon S.H., Corcoy R. (2020) Both glycaemic control and insulin dose during pregnancy in women with type 1 diabetes are associated with neonatal anthropometric measures and placental weight. DIABETES-METAB RES, (), -.
IF: 4,876
García-Patterson A, Balsells M, Bartha JL, Solà I, Corcoy R. Current evidence about better perinatal outcomes associated to one step approach in the diagnosis of gestational diabetes mellitus is not of high quality. (2020) J MATERN-FETAL NEONATAL MED. 1-3. doi: 10.1080/14767058.2020.1759532.
IF: 2,398
Genua I., Ramos A., Caimari F., Balague C., Sanchez-Quesada J.L., Perez A., Minambres I. (2020) Effects of Bariatric Surgery on HDL Cholesterol. OBES SURG, 30 (5), 1793-1798.
IF: 4,129
Genua I, Tuneu L, Ramos A, Stantonyonge N, Caimari F, Balagué C, Fernández- Ananin S, Sánchez-Quesada JL, Pérez A, Miñambres I. Effectiveness of Bariatric Surgery in Patients with the Metabolically Healthy Obese Phenotype. (2020) OBES SURG. doi: 10.1007/s11695-020-04967-6.
IF: 4,129
Granado-Casas M, Martin M, Martínez-Alonso M, Alcubierre N, Hernández M, Alonso N, Castelblanco E, Mauricio D.The Mediterranean Diet is Associated with an Improved Quality of Life in Adults with Type 1 Diabetes. (2020) NUTRIENTS 12:E131. doi: 10.3390/nu12010131.
IF: 5,717
Gras-Cabrerizo, Juan R.; Rodríguez-Álvarez, Fernando; Gomez-Anson, Beatriz; Cubero-Marcos, José María; Martel-Martin, Maria; Granell-Moreno, Esther; Lopez-Vilas, Montserrat; Montserrat-Gili, Joan Ramon; Massegur-Solench, Humbert.Management of Patients With Graves Orbitopathy Using Endonasal Endoscopic Techniques. (2020) J CRANIOFAC SURG. doi: 10.1097/SCS.0000000000007107. Online ahead of print.
IF: 1,046
Harreiter J, Desoye G, van Poppel MNM, Kautzky-Willer A, Dunne F, Corcoy R, Devlieger R, Simmons D; DALI Consortium, Adelantado JM, Damm P, Mathiesen ER, Jensen DM, Anderson LLT, Lapolla A, Dalfrà MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Hill DJ, Snoek FJ. Correction to: The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have we Learned from the DALI Studies? (2020) CURR DIABETES REP. 20:35. doi: 10.1007/s11892-020-01322-y.
IF: 4,810
Immanuel J., Simmons D., Desoye G., Corcoy R., Adelantado J.M., Devlieger R., Lapolla A., Dalfra M.G., Bertolotto A., Harreiter J., Wender-Ozegowska E., Zawiejska A., Dunne F.P., Damm P., Mathiesen E.R., Jensen D.M., Andersen L.L.T., Hill D.J., Jelsma J.G.M., Snoek F.J., Scharnagl H., Galjaard S., Kautzky-Willer A., VAN Poppel M.N.M. (2020) Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women. DIABETES RES CLIN PR, 168 (), -.
IF: 5,602
Jayaraman S., Chavez O.R., Perez A., Minambres I., Sanchez-Quesada J.L., Gursky O. (2020) Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia. BBA-MOL CELL BIOL L, 1865 (8), -.
IF: 4,698
Jiménez Navarro M, Castro A, Ballesteros Pradas S, Cruzado Álvarez C, Gómez Doblas JJ, Marzal Martín D, Del Prado S, Valencia Serrano F, Bretón I, Gómez Peralta F, Mauricio D, Soto González A, Barrios V, Cordero A, Cosin-Sales J, García-Moll X, et al. Comments on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular disease. (2020) REV ESP CARDIOL 73:354-360. doi: 10.1016/j.rec.2019.11.018.
IF: 4,753
Khunti K., Giorgino F., Berard L., Mauricio D., Harris S.B. (2020) The importance of the initial period of basal insulin titration in people with diabetes. DIABETES OBES METAB, 22 (5), 722-733.
IF: 6,577
Lapena C., Borras E., Digon C., Aznar R., Del Val Garcia J.L., Castelblanco E., Garaikoetxea A., Laguna V. (2020) Effectiveness of a comprehensive care protocol in patients with new diagnoses of type 2 diabetes mellitus and associated comorbidities in primary care: study protocol of a quasi-experimental trial. BMJ OPEN, 10 (6), e033725-.
IF: 2,692
Lázaro Martínez JL, Almaraz MC, Álvarez Hermida Á, Blanes Mompó I, Escudero Rodríguez JR, García Morales EA, March García JR, Rivera San Martín G, Rodríguez Sáenz de Buruaga V, Rosendo Fernández JM, Rubio García JA, Mauricio D. Consensus document on actions to prevent and to improve the management of diabetic foot in Spain. (2020) ENDOCRINOL DIAB NUTR S2530-0164(20)30209-3. doi: 10.1016/j.endinu.2020.08.001.
IF: 1,417
Lima R.A., Desoye G., Simmons D., Devlieger R., Galjaard S., Corcoy R., Adelantado J.M., Dunne F., Harreiter J., Kautzky-Willer A., Damm P., Mathiesen E.R., Jensen D.M., Andersen L.-L., Tanvig M., Lapolla A., Dalfra M.G., Bertolotto A., Wender-Ozegowska E., Zawiejska A., Hill D.J., Snoek F.J., Jelsma J.G.M., van Poppel M.N.M. (2020) Temporal relationships between maternal metabolic parameters with neonatal adiposity in women with obesity differ by neonatal sex: Secondary analysis of the DALI study. PEDIATR OBES, 15 (7), -.
IF: 4,000
Ma D, Luque-Fernandez MA, Bogdanet D, Desoye G, Dunne F, Halperin JA; DALI Core Investigator Group. Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns. (2020) J CLIN ENDOCR METAB. 105(4):e1033–40. doi: 10.1210/clinem/dgaa087.
IF: 5,958
María María MA, Ramos A, Martínez Roldán MJ, Pujol Giménez I, Pérez A. Implementation of an inpatient hyperglycemia management program incorporating a nurse consultant. (2020) ENDOCRINOL DIAB NUTR.67:461-468. doi: 10.1016/j.endinu.2019.07.010.
IF: 1,417
Martinez-Gonzalez D, Dòria M, Martínez-Alonso M, Alcubierre N, Valls J, Verdú-Soriano J, Granado-Casas M, Mauricio D.Adaptation and Validation of the Diabetic Foot Ulcer Scale-Short Form in Spanish Subjects. (2020) J CLIN MED 9:2497. doi: 10.3390/jcm9082497.
IF: 4,241
Mata-Cases M, Mahon J, Mauricio D, Franch-Nadal J, Real J, Hex N. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs. (2020) BMC HEALTH SERV RES 20:803. doi: 10.1186/s12913-020-05360-w.
IF: 2,655
Mata-Cases M., Rodriguez-Sanchez B., Mauricio D., Real J., Vlacho B., Franch-Nadal J., Oliva J. (2020) The association between poor glycemic control and health care costs in people with diabetes: A population-based study. DIABETES CARE, 43 (4), 751-758.
IF: 19,112
Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. (2020) J ENDOCRINOL INVEST. 1–2. doi: 10.1007/s40618-020-01366-7 [Epub ahead of print].
IF: 4,256
Mauricio D., Alonso N., Gratacos M. (2020) Chronic Diabetes Complications: The Need to Move beyond Classical Concepts. TRENDS ENDOCRIN MET, (), -.
IF: 12,015
Mauricio D, Castelblanco E, Alonso N. Cholesterol and Inflammation in Atherosclerosis: An Immune-Metabolic Hypothesis. (2020) NUTRIENTS 12:2444. doi: 10.3390/nu12082444.
IF: 5,717
Mauricio D, Westerbacka J, Nicholls C, Wu J, Gupta R, Eliasson B. How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting? (2020) DIABETES OBES METAB. doi: 10.1111/dom.14264. Online ahead of print.
IF: 6,577
Minambres I., Corcoy R., Weetman A.P., Kemp E.H. (2020) Autoimmune hypercalcemia due to autoantibodies against the calcium-sensing receptor. J CLIN ENDOCR METAB, 105 (7), -.
IF: 5,958
Minambres I., Sanchez-Hernandez J., Cuixart G., Sanchez-Pinto A., Sarroca J., Perez A. (2020) Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: An epidemiological study Caracterización del fenotipo de cintura hipertrigliceridémica en pacientes con diabetes mellitus tipo 2 en España: un estudio epidemiológico. REV CLIN ESP, (), -.
IF: 1,556
Mishra R., Akerlund M., Cousminer D.L., Ahlqvist E., Bradfield J.P., Chesi A., Hodge K.M., Guy V.C., Brillon D.J., Pratley R.E., Rickels M.R., Vella A., Ovalle F., Harris R.I., Melander O., Varvel S., Hakonarson H., Froguel P., Lonsdale J.T., Mauricio D., Schloot N.C., Khunti K., Greenbaum C.J., Yderstraede K.B., Tuomi T., Voight B.F., Schwartz S., Boehm B.O., Groop L., Leslie R.D., Grant S.F.A. (2020) Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC. DIABETES CARE, 43 (2), 418-425.
IF: 19,112
Navas-Madroñal M, Castelblanco E, Camacho M, Consegal M, Ramirez-Morros A, Sarrias MR, Perez P, Alonso N, Galán M, Mauricio D. Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis. (2020) INT J MOL SCI 21:7360. doi: 10.3390/ijms21197360.
IF: 5,923
Neoh SL, Yamamoto JM, Feig DS, Murphy HR; CONCEPTT Collaborative Group. Dietary Patterns of Insulin Pump and Multiple Daily Injection Users During Type 1 Diabetes Pregnancy. (2020) DIABETES CARE. 43:e5-e7. doi: 10.2337/dc19-1908.
IF: 19,112
Oliveira SC, Neves JS, Pérez A, Carvalho D. Maturity-onset diabetes of the young: From a molecular basis perspective toward the clinical phenotype and proper management. (2020) ENDOCRINOL DIAB NUTR.67:137-147. doi: 10.1016/j.endinu.2019.07.012.
IF: 1,417
Pérez A, Carrasco-Sánchez FJ, González C, et al. Efficacy and safety of insulin glargine 300 U/ml (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial. (2020) BMJ OPEN DIABETES RES CARE. 8:e001518. doi: 10.1136/bmjdrc-2020-001518.
IF: 3,388
Pérez A, Ramos A, Carreras G. Insulin Therapy in Hospitalized Patients. (2020) AM J THER. 27:e71-e78. DOI: 0.1097/MJT.0000000000001078.
IF: 2,688
Puig N, Miñambres I, Benítez S, et al. Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia. (2020) BIOMEDICINES. 8:6. doi: 10.3390/biomedicines8010006.
IF: 6,081
Revilla G., Cedo L., Tondo M., Moral A., Perez J.I., Corcoy R., Lerma E., Fuste V., Reddy S.T., Blanco-Vaca F., Mato E., Escola-Gil J.C., LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies (2020) SEMIN CANCER BIOL.
IF: 15,707
Rivas-Urbina A, Rull A, Aldana-Ramos J, Santos D, Puig N, Farre-Cabrerizo N, Benitez S, Perez A, de Gonzalo-Calvo D, Escola-Gil JC, Julve J, Ordoñez-Llanos J, Sanchez-Quesada JL Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. (2020) BIOMOLECULES. 10:829. doi: 10.3390/biom10060829.
IF: 4,879
Sampedro F, Stantonyonge N, Martínez-Horta S, Alcolea D, Lleó A, Muñoz L, Pérez-González R, Marín-Lahoz J, Gómez-Ansón B, Chico A. Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia. (2020) BMJ OPEN DIABETES RES CARE 8:e001516. doi: 10.1136/bmjdrc-2020-001516.
IF: 3,388
Scott EM, Feig DS, Murphy HR, Law GR; CONCEPTT Collaborative Group. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes. (2020) DIABETES CARE. 43(6):1178-1184. doi: 10.2337/dc19-2527.
IF: 19,112
Vazquez-Justes D., Sanahuja J., Diez J., Rubinat E., Begue R., Salas C., Vicandi C., Gil M.I., Purroy F., Mauricio D. (2020) Incidental findings on brain MRI in a cohort of diabetic patients. J NEURORADIOLOGY, 47 (5), 343-348.
IF: 3,447
Vilanova, MB; Franch-Nadal, J; Falguera, M; Marsal, JR; Canivell, S; Rubinat, E; Miro, N; Mollo, A; Mata-Cases, M; Gratacos, M; Castelblanco, E; Mauricio, D. Prediabetes Is Independently Associated with Subclinical Carotid Atherosclerosis: An Observational Study in a Non-Urban Mediterranean Population. (2020) J CLIN MED 9:2139. doi: 10.3390/jcm9072139.
IF: 4,241
Vlacho B, Mundet-Tudurí X, Mata-Cases M, Vallès-Callol JA, Real J, Farré M, Cos FX, Khunti K, Mauricio D, Franch-Nadal J. Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area: A retrospective cohort study. (2020) DIABETES RES CLIN PR 171:108616. doi: 10.1016/j.diabres.
IF: 5,602
Xie X, Liu J, Pujol I, López A, Martínez MJ, García-Patterson A, Adelantado JM, Ginovart G, Corcoy R. Inadequate Weight Gain According to the Institute of Medicine 2009 Guidelines in Women with Gestational Diabetes: Frequency, Clinical Predictors, and the Association with Pregnancy Outcomes. (2020) J CLIN MED. 9:3343. doi: 10.3390/jcm9103343.
IF: 4,241
